Research and Development
This group unites PF patients, caregivers, researchers and medical professionals in a platform to... View more
BBT-877 Greatly Reduces Lung Fibrosis, Early Study Shows
-
BBT-877 Greatly Reduces Lung Fibrosis, Early Study Shows
The treatment candidate BBT-877 strongly reduced lung fibrosis compared to other compounds, preclinical results show.
What are your thought about this?
Sorry, there were no replies found.
Log in to reply.